July 23, 2013
Lyo Inuyama, Operating Officer of Bayer Bayer Yakuhin’s anticancer agent Stivarga (regorafenib) has been provided to patients ailing from gastrointestinal stromal tumors (GIST) using the same scheme as the health ministry’s proposed access system, virtually becoming the first drug to...read more